Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Stage II in the development of Eph/ephrin based tumor targeting reagents: optimisation of drug efficacy and delivery
Lackmann, Martin
(Primary Chief Investigator (PCI))
Boyd, Andrew Wallace
(Chief Investigator (CI))
Scott, Andrew
(Chief Investigator (CI))
Treutlein, Herbert
(Chief Investigator (CI))
Biochemistry & Molecular Biology
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
1/07/04
→
30/06/05
Funding
National Health and Medical Research Council (NHMRC) (Australia):
A$204,125.00
View all
View less